Page last updated: 2024-12-07

homoorientin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Homoorientin is a flavonoid compound found in various plants, including buckwheat, barley, and rice. It has been shown to possess antioxidant and anti-inflammatory properties. Research on homoorientin is ongoing due to its potential health benefits, including its ability to protect against oxidative stress, reduce inflammation, and potentially inhibit the growth of cancer cells. The synthesis of homoorientin is complex and often involves multiple steps. It is typically produced via enzymatic reactions in plants. The specific effects of homoorientin on the human body are still being investigated, but studies suggest that it may have a positive impact on cardiovascular health and cognitive function. Further research is needed to fully understand the therapeutic potential of homoorientin.'

homoorientin: isolated from Swertia japonica; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

FloraRankFlora DefinitionFamilyFamily Definition
SwertiagenusA plant genus of the family GENTIANACEAE. It is a source of swertiapuniside and IRIDOID GLYCOSIDES.[MeSH]GentianaceaeA plant family of the order Gentianales, subclass Asteridae, class Magnoliopsida.[MeSH]

Cross-References

ID SourceID
PubMed CID114776
CHEMBL ID239559
CHEBI ID17965
SCHEMBL ID23761
MeSH IDM0161798

Synonyms (51)

Synonym
2-(3,4-dihydroxyphenyl)-6-beta-d-glucopyranosyl-5,7-dihydroxy-4h-1-benzopyran-4-one
(1s)-1,5-anhydro-1-[2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4-oxo-4h-chromen-6-yl]-d-glucitol
luteolin-6-c-beta-d-glucoside
CHEBI:17965 ,
4261-42-1
isoorientin ,
homoorientin
C01821
luteolin-6-c-b-d-glucopyranoside
2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-6-[(2s,3r,4r,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]chromen-4-one
NCGC00163566-01
CHEMBL239559
MLS002473101
smr001397203
iso-orientin
6-glc-luteolin
unii-a37342tix1
4h-1-benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-6-beta-d-glucopyranosyl-5,7-dihydroxy-
a37342tix1 ,
luteolin-6-c-glucoside
HMS2225D20
S9248
AKOS015896766
lutonaretin
4h-1-benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-6-.beta.-d-glucopyranosyl-5,7-dihydroxy-
lespecapitioside
61383-35-5
CCG-208392
SCHEMBL23761
AC-34983
Q-100474
CS-7515
homoori-entin
mfcd00017433
isoorientin, analytical standard
isoorientin, primary pharmaceutical reference standard
isoorientin, >=98.0% (hplc)
isoorientin, >=98% (hplc)
bdbm50487756
HY-N0767
2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-6-((2s,3r,4r,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2h-pyran-2-yl)-4h-chromen-4-one
Q3155592
ODBRNZZJSYPIDI-VJXVFPJBSA-N
homoorientin; isoorientin
DTXSID50962609
AS-56302
2-[3,4-bis(oxidanyl)phenyl]-6-[(2s,3r,4r,5s,6r)-6-(hydroxymethyl)-3,4,5-tris(oxidanyl)oxan-2-yl]-5,7-bis(oxidanyl)chromen-4-one
h9r ,
I1087
(1s)-1,5-anhydro-1-(2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4-oxo-4h-chromen-6-yl)-d-glucitol
2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-6-((2s,3r,4r,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl)chromen-4-one

Research Excerpts

Pharmacokinetics

ExcerptReferenceRelevance
"To establish a UPLC-MS/MS analysical method for simultaneous determination of concentrations of isoorientin, scutellarin and cynaroside in rat plasma and to study their pharmacokinetic characteristics after intravenous injection of 3 doses of Fufang Hongcao in rats."( [Simultaneous determination of isoorientin, scutellarin and cynaroside in rat plasma and pharmacokinetics by UPLC-MS/MS].
He, F; Huang, Y; Lan, Y; Wang, Y; Zhang, Z; Zheng, L, 2012
)
0.38
"The above men tioned method is so specific, rapid, sensitive that it is suitable for pharmacokinetic studies of Fufang Hongcao injection in rats."( [Simultaneous determination of isoorientin, scutellarin and cynaroside in rat plasma and pharmacokinetics by UPLC-MS/MS].
He, F; Huang, Y; Lan, Y; Wang, Y; Zhang, Z; Zheng, L, 2012
)
0.38
" The metabolic and plasma pharmacokinetic profiles of isoorientin were investigated in rats."( Metabolism and plasma pharmacokinetics of isoorientin, a natural active ingredient, in Sprague-Dawley male rats after oral and intravenous administration.
Lin, X; Shi, P; Yao, H, 2015
)
0.42

Bioavailability

ExcerptReferenceRelevance
" Isoorientin showed low oral bioavailability (8."( Metabolism and plasma pharmacokinetics of isoorientin, a natural active ingredient, in Sprague-Dawley male rats after oral and intravenous administration.
Lin, X; Shi, P; Yao, H, 2015
)
0.42
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (2)

RoleDescription
radical scavengerA role played by a substance that can react readily with, and thereby eliminate, radicals.
antineoplastic agentA substance that inhibits or prevents the proliferation of neoplasms.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
tetrahydroxyflavoneAny hydroxyflavone carrying four hydroxy substituents.
flavone C-glycosideAny C-glycosyl compound arising formally from the elimination of water from a glycosidic hydroxy group and an H atom bound to a flavone skeleton, thus creating a C-C bond.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (17)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASEHomo sapiens (human)Potency3.16230.003245.467312,589.2998AID2517
Chain A, TYROSYL-DNA PHOSPHODIESTERASEHomo sapiens (human)Potency79.43280.004023.8416100.0000AID485290
Chain A, Putative fructose-1,6-bisphosphate aldolaseGiardia intestinalisPotency17.74070.140911.194039.8107AID2451
Chain A, JmjC domain-containing histone demethylation protein 3AHomo sapiens (human)Potency38.14560.631035.7641100.0000AID504339
phosphopantetheinyl transferaseBacillus subtilisPotency39.81070.141337.9142100.0000AID1490
ATAD5 protein, partialHomo sapiens (human)Potency18.34890.004110.890331.5287AID504467
GLS proteinHomo sapiens (human)Potency22.38720.35487.935539.8107AID624170
importin subunit beta-1 isoform 1Homo sapiens (human)Potency39.81075.804836.130665.1308AID540263
flap endonuclease 1Homo sapiens (human)Potency29.90330.133725.412989.1251AID588795
snurportin-1Homo sapiens (human)Potency39.81075.804836.130665.1308AID540263
peptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)Potency44.66840.425612.059128.1838AID504891
DNA polymerase eta isoform 1Homo sapiens (human)Potency22.38720.100028.9256213.3130AID588591
DNA polymerase iota isoform a (long)Homo sapiens (human)Potency36.42610.050127.073689.1251AID588590
lethal(3)malignant brain tumor-like protein 1 isoform IHomo sapiens (human)Potency31.62280.075215.225339.8107AID485360
DNA polymerase kappa isoform 1Homo sapiens (human)Potency19.95260.031622.3146100.0000AID588579
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
rac GTPase-activating protein 1 isoform aHomo sapiens (human)IC50 (µMol)40.92007.390057.8904301.2400AID624330
Glycogen synthase kinase-3 betaHomo sapiens (human)IC50 (µMol)185.00000.00060.801310.0000AID1872912
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (73)

Processvia Protein(s)Taxonomy
positive regulation of gene expressionGlycogen synthase kinase-3 betaHomo sapiens (human)
negative regulation of gene expressionGlycogen synthase kinase-3 betaHomo sapiens (human)
ER overload responseGlycogen synthase kinase-3 betaHomo sapiens (human)
peptidyl-serine phosphorylationGlycogen synthase kinase-3 betaHomo sapiens (human)
intracellular signal transductionGlycogen synthase kinase-3 betaHomo sapiens (human)
negative regulation of apoptotic processGlycogen synthase kinase-3 betaHomo sapiens (human)
positive regulation of protein export from nucleusGlycogen synthase kinase-3 betaHomo sapiens (human)
epithelial to mesenchymal transitionGlycogen synthase kinase-3 betaHomo sapiens (human)
positive regulation of cell-matrix adhesionGlycogen synthase kinase-3 betaHomo sapiens (human)
glycogen metabolic processGlycogen synthase kinase-3 betaHomo sapiens (human)
protein phosphorylationGlycogen synthase kinase-3 betaHomo sapiens (human)
mitochondrion organizationGlycogen synthase kinase-3 betaHomo sapiens (human)
dopamine receptor signaling pathwayGlycogen synthase kinase-3 betaHomo sapiens (human)
circadian rhythmGlycogen synthase kinase-3 betaHomo sapiens (human)
positive regulation of autophagyGlycogen synthase kinase-3 betaHomo sapiens (human)
positive regulation of gene expressionGlycogen synthase kinase-3 betaHomo sapiens (human)
peptidyl-serine phosphorylationGlycogen synthase kinase-3 betaHomo sapiens (human)
peptidyl-threonine phosphorylationGlycogen synthase kinase-3 betaHomo sapiens (human)
viral protein processingGlycogen synthase kinase-3 betaHomo sapiens (human)
hippocampus developmentGlycogen synthase kinase-3 betaHomo sapiens (human)
establishment of cell polarityGlycogen synthase kinase-3 betaHomo sapiens (human)
maintenance of cell polarityGlycogen synthase kinase-3 betaHomo sapiens (human)
negative regulation of cell migrationGlycogen synthase kinase-3 betaHomo sapiens (human)
regulation of axon extensionGlycogen synthase kinase-3 betaHomo sapiens (human)
neuron projection developmentGlycogen synthase kinase-3 betaHomo sapiens (human)
negative regulation of protein-containing complex assemblyGlycogen synthase kinase-3 betaHomo sapiens (human)
positive regulation of protein-containing complex assemblyGlycogen synthase kinase-3 betaHomo sapiens (human)
positive regulation of protein ubiquitinationGlycogen synthase kinase-3 betaHomo sapiens (human)
positive regulation of protein bindingGlycogen synthase kinase-3 betaHomo sapiens (human)
positive regulation of proteasomal ubiquitin-dependent protein catabolic processGlycogen synthase kinase-3 betaHomo sapiens (human)
negative regulation of phosphoprotein phosphatase activityGlycogen synthase kinase-3 betaHomo sapiens (human)
regulation of microtubule-based processGlycogen synthase kinase-3 betaHomo sapiens (human)
intracellular signal transductionGlycogen synthase kinase-3 betaHomo sapiens (human)
cellular response to interleukin-3Glycogen synthase kinase-3 betaHomo sapiens (human)
regulation of circadian rhythmGlycogen synthase kinase-3 betaHomo sapiens (human)
proteasome-mediated ubiquitin-dependent protein catabolic processGlycogen synthase kinase-3 betaHomo sapiens (human)
positive regulation of GTPase activityGlycogen synthase kinase-3 betaHomo sapiens (human)
positive regulation of cell differentiationGlycogen synthase kinase-3 betaHomo sapiens (human)
negative regulation of osteoblast differentiationGlycogen synthase kinase-3 betaHomo sapiens (human)
negative regulation of glycogen biosynthetic processGlycogen synthase kinase-3 betaHomo sapiens (human)
positive regulation of cilium assemblyGlycogen synthase kinase-3 betaHomo sapiens (human)
positive regulation of protein catabolic processGlycogen synthase kinase-3 betaHomo sapiens (human)
protein autophosphorylationGlycogen synthase kinase-3 betaHomo sapiens (human)
regulation of protein export from nucleusGlycogen synthase kinase-3 betaHomo sapiens (human)
regulation of dendrite morphogenesisGlycogen synthase kinase-3 betaHomo sapiens (human)
regulation of axonogenesisGlycogen synthase kinase-3 betaHomo sapiens (human)
canonical Wnt signaling pathwayGlycogen synthase kinase-3 betaHomo sapiens (human)
excitatory postsynaptic potentialGlycogen synthase kinase-3 betaHomo sapiens (human)
regulation of microtubule cytoskeleton organizationGlycogen synthase kinase-3 betaHomo sapiens (human)
negative regulation of calcineurin-NFAT signaling cascadeGlycogen synthase kinase-3 betaHomo sapiens (human)
superior temporal gyrus developmentGlycogen synthase kinase-3 betaHomo sapiens (human)
cellular response to retinoic acidGlycogen synthase kinase-3 betaHomo sapiens (human)
negative regulation of canonical Wnt signaling pathwayGlycogen synthase kinase-3 betaHomo sapiens (human)
extrinsic apoptotic signaling pathwayGlycogen synthase kinase-3 betaHomo sapiens (human)
extrinsic apoptotic signaling pathway in absence of ligandGlycogen synthase kinase-3 betaHomo sapiens (human)
presynaptic modulation of chemical synaptic transmissionGlycogen synthase kinase-3 betaHomo sapiens (human)
neuron projection organizationGlycogen synthase kinase-3 betaHomo sapiens (human)
regulation of microtubule anchoring at centrosomeGlycogen synthase kinase-3 betaHomo sapiens (human)
regulation of cellular response to heatGlycogen synthase kinase-3 betaHomo sapiens (human)
negative regulation of protein localization to nucleusGlycogen synthase kinase-3 betaHomo sapiens (human)
regulation of long-term synaptic potentiationGlycogen synthase kinase-3 betaHomo sapiens (human)
positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathwayGlycogen synthase kinase-3 betaHomo sapiens (human)
negative regulation of protein acetylationGlycogen synthase kinase-3 betaHomo sapiens (human)
negative regulation of extrinsic apoptotic signaling pathway via death domain receptorsGlycogen synthase kinase-3 betaHomo sapiens (human)
positive regulation of protein localization to ciliumGlycogen synthase kinase-3 betaHomo sapiens (human)
negative regulation of dopaminergic neuron differentiationGlycogen synthase kinase-3 betaHomo sapiens (human)
cellular response to amyloid-betaGlycogen synthase kinase-3 betaHomo sapiens (human)
positive regulation of protein localization to centrosomeGlycogen synthase kinase-3 betaHomo sapiens (human)
beta-catenin destruction complex disassemblyGlycogen synthase kinase-3 betaHomo sapiens (human)
negative regulation of type B pancreatic cell developmentGlycogen synthase kinase-3 betaHomo sapiens (human)
negative regulation of glycogen (starch) synthase activityGlycogen synthase kinase-3 betaHomo sapiens (human)
negative regulation of mesenchymal stem cell differentiationGlycogen synthase kinase-3 betaHomo sapiens (human)
negative regulation of TOR signalingGlycogen synthase kinase-3 betaHomo sapiens (human)
regulation of neuron projection developmentGlycogen synthase kinase-3 betaHomo sapiens (human)
cell differentiationGlycogen synthase kinase-3 betaHomo sapiens (human)
insulin receptor signaling pathwayGlycogen synthase kinase-3 betaHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (17)

Processvia Protein(s)Taxonomy
protease bindingGlycogen synthase kinase-3 betaHomo sapiens (human)
p53 bindingGlycogen synthase kinase-3 betaHomo sapiens (human)
protein kinase activityGlycogen synthase kinase-3 betaHomo sapiens (human)
protein serine/threonine kinase activityGlycogen synthase kinase-3 betaHomo sapiens (human)
protein bindingGlycogen synthase kinase-3 betaHomo sapiens (human)
ATP bindingGlycogen synthase kinase-3 betaHomo sapiens (human)
beta-catenin bindingGlycogen synthase kinase-3 betaHomo sapiens (human)
kinase activityGlycogen synthase kinase-3 betaHomo sapiens (human)
protein kinase bindingGlycogen synthase kinase-3 betaHomo sapiens (human)
ubiquitin protein ligase bindingGlycogen synthase kinase-3 betaHomo sapiens (human)
protein kinase A catalytic subunit bindingGlycogen synthase kinase-3 betaHomo sapiens (human)
dynactin bindingGlycogen synthase kinase-3 betaHomo sapiens (human)
tau protein bindingGlycogen synthase kinase-3 betaHomo sapiens (human)
tau-protein kinase activityGlycogen synthase kinase-3 betaHomo sapiens (human)
NF-kappaB bindingGlycogen synthase kinase-3 betaHomo sapiens (human)
RNA polymerase II-specific DNA-binding transcription factor bindingGlycogen synthase kinase-3 betaHomo sapiens (human)
protein serine kinase activityGlycogen synthase kinase-3 betaHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (14)

Processvia Protein(s)Taxonomy
glutamatergic synapseGlycogen synthase kinase-3 betaHomo sapiens (human)
nucleusGlycogen synthase kinase-3 betaHomo sapiens (human)
nucleoplasmGlycogen synthase kinase-3 betaHomo sapiens (human)
cytoplasmGlycogen synthase kinase-3 betaHomo sapiens (human)
mitochondrionGlycogen synthase kinase-3 betaHomo sapiens (human)
centrosomeGlycogen synthase kinase-3 betaHomo sapiens (human)
cytosolGlycogen synthase kinase-3 betaHomo sapiens (human)
plasma membraneGlycogen synthase kinase-3 betaHomo sapiens (human)
axonGlycogen synthase kinase-3 betaHomo sapiens (human)
dendriteGlycogen synthase kinase-3 betaHomo sapiens (human)
beta-catenin destruction complexGlycogen synthase kinase-3 betaHomo sapiens (human)
presynapseGlycogen synthase kinase-3 betaHomo sapiens (human)
postsynapseGlycogen synthase kinase-3 betaHomo sapiens (human)
Wnt signalosomeGlycogen synthase kinase-3 betaHomo sapiens (human)
cytosolGlycogen synthase kinase-3 betaHomo sapiens (human)
axonGlycogen synthase kinase-3 betaHomo sapiens (human)
nucleusGlycogen synthase kinase-3 betaHomo sapiens (human)
cytoplasmGlycogen synthase kinase-3 betaHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (51)

Assay IDTitleYearJournalArticle
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID504812Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID651635Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression
AID504810Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID1745845Primary qHTS for Inhibitors of ATXN expression
AID697852Inhibition of electric eel AChE at 2 mg/ml by Ellman's method2012Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
AID504312Antioxidant activity against AAPH-induced lipid peroxidation assessed as trolox equivalent of peroxy radical scavenging activity after 10 mins by ORAC assay2010Journal of natural products, Sep-24, Volume: 73, Issue:9
Antioxidant flavone glycosides from the leaves of Fargesia robusta.
AID1236853Inhibition of Bacillus stearothermophilus alpha-glucosidase2015Bioorganic & medicinal chemistry, Jul-01, Volume: 23, Issue:13
Acylated glucosylflavones as α-glucosidase inhibitors from Tinospora crispa leaf.
AID304975Antifungal activity against Trichophyton mentagrophytes by broth micro-dilution technique2007Bioorganic & medicinal chemistry letters, Jan-01, Volume: 17, Issue:1
New antifungal flavonoid glycoside from Vitex negundo.
AID403602Inhibition of noradrenaline-induced Wistar rat thoracic aorta phasic contraction in high K+ medium at 150 uM pretreated 15 mins before addition of Ca2+ and K+ relative to control1997Journal of natural products, Aug, Volume: 60, Issue:8
A new flavone C-glycoside and antiplatelet and vasorelaxing flavones from Gentiana arisanensis.
AID304973Antifungal activity against Cryptococcus neoformans by broth micro-dilution technique2007Bioorganic & medicinal chemistry letters, Jan-01, Volume: 17, Issue:1
New antifungal flavonoid glycoside from Vitex negundo.
AID403607Inhibition of noradrenaline-induced Wistar rat thoracic aorta tonic contraction in high K+ medium at 150 uM pretreated 15 mins before addition of Ca2+ and K+ relative to control1997Journal of natural products, Aug, Volume: 60, Issue:8
A new flavone C-glycoside and antiplatelet and vasorelaxing flavones from Gentiana arisanensis.
AID697853Inhibition of horse BChE at 2 mg/ml by Ellman's method2012Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
AID1872913Neuroprotective activity against human SH-SY5Y cells pretreated for 1 hr followed by muMAbeta42 measured after 72 hrs2022European journal of medicinal chemistry, Jun-05, Volume: 236Development of inhibitors targeting glycogen synthase kinase-3β for human diseases: Strategies to improve selectivity.
AID658255Cytotoxicity against human Huh7.5.1 cells by MTT assay2012European journal of medicinal chemistry, Jun, Volume: 52Discovery of flavonoid derivatives as anti-HCV agents via pharmacophore search combining molecular docking strategy.
AID551461Antioxidant activity assessed as peroxyl radical scavenging activity at 1 to 2 uM by ORAC assay2011Bioorganic & medicinal chemistry letters, Jan-15, Volume: 21, Issue:2
Antioxidant activity of a new C-glycosylflavone from the leaves of Ficus microcarpa.
AID304974Antifungal activity against Sporothrix schenckii by broth micro-dilution technique2007Bioorganic & medicinal chemistry letters, Jan-01, Volume: 17, Issue:1
New antifungal flavonoid glycoside from Vitex negundo.
AID304972Antifungal activity against Candida albicans by broth micro-dilution technique2007Bioorganic & medicinal chemistry letters, Jan-01, Volume: 17, Issue:1
New antifungal flavonoid glycoside from Vitex negundo.
AID658254Antiviral activity against HCV JFH-1 J399EM infected in Human Huh7.5.1 cells assessed as suppression of viral replication at 50 uM after 72 hrs by EGFP assay2012European journal of medicinal chemistry, Jun, Volume: 52Discovery of flavonoid derivatives as anti-HCV agents via pharmacophore search combining molecular docking strategy.
AID403582Inhibition of thrombin-induced platelet aggregation in rabbit plasma at 300 uM preincubated 3 mins before addition of thrombin by turbidimetric method1997Journal of natural products, Aug, Volume: 60, Issue:8
A new flavone C-glycoside and antiplatelet and vasorelaxing flavones from Gentiana arisanensis.
AID304968Antibacterial activity against Klebsiella pneumoniae by broth micro-dilution technique2007Bioorganic & medicinal chemistry letters, Jan-01, Volume: 17, Issue:1
New antifungal flavonoid glycoside from Vitex negundo.
AID551462Antioxidant activity assessed as copper ion radical scavenging activity at 2 uM2011Bioorganic & medicinal chemistry letters, Jan-15, Volume: 21, Issue:2
Antioxidant activity of a new C-glycosylflavone from the leaves of Ficus microcarpa.
AID566616Antiproliferative activity against human HepG2 cells at 6.25 uM after 48 hrs by MTT assay2010Journal of natural products, Dec-27, Volume: 73, Issue:12
Spectroscopic characterization and antiproliferative activity on HepG2 human hepatoblastoma cells of flavonoid C-glycosides from Petrorhagia velutina.
AID403584Inhibition of arachidonic acid-induced platelet aggregation in rabbit plasma at 300 uM preincubated 3 mins before addition of thrombin by turbidimetric method1997Journal of natural products, Aug, Volume: 60, Issue:8
A new flavone C-glycoside and antiplatelet and vasorelaxing flavones from Gentiana arisanensis.
AID304977Antifungal activity against Candida parapsilosis ATCC 22019 by broth micro-dilution technique2007Bioorganic & medicinal chemistry letters, Jan-01, Volume: 17, Issue:1
New antifungal flavonoid glycoside from Vitex negundo.
AID504311Antioxidant activity assessed as trolox equivalent of ABTS radical scavenging activity after 12 to 16 hrs by spectrophotometry2010Journal of natural products, Sep-24, Volume: 73, Issue:9
Antioxidant flavone glycosides from the leaves of Fargesia robusta.
AID566613Antiproliferative activity against human HepG2 cells at 6.25 uM after 24 hrs by MTT assay2010Journal of natural products, Dec-27, Volume: 73, Issue:12
Spectroscopic characterization and antiproliferative activity on HepG2 human hepatoblastoma cells of flavonoid C-glycosides from Petrorhagia velutina.
AID403591Inhibition of collagen-induced platelet aggregation in rabbit plasma at 300 uM preincubated 3 mins before addition of thrombin by turbidimetric method1997Journal of natural products, Aug, Volume: 60, Issue:8
A new flavone C-glycoside and antiplatelet and vasorelaxing flavones from Gentiana arisanensis.
AID429280Osteogenic activity in neonatal Sprague-Dawley rat osteoblasts assessed as stimulation of alkaline phosphatase activity at 100 pM to 10 nM2009Bioorganic & medicinal chemistry letters, Aug-15, Volume: 19, Issue:16
Ulmosides A and B: flavonoid 6-C-glycosides from Ulmus wallichiana, stimulating osteoblast differentiation assessed by alkaline phosphatase.
AID551463Metal chelating activity of the compound at 1 to 2 uM2011Bioorganic & medicinal chemistry letters, Jan-15, Volume: 21, Issue:2
Antioxidant activity of a new C-glycosylflavone from the leaves of Ficus microcarpa.
AID304969Antibacterial activity against Escherichia coli by broth micro-dilution technique2007Bioorganic & medicinal chemistry letters, Jan-01, Volume: 17, Issue:1
New antifungal flavonoid glycoside from Vitex negundo.
AID338974Inhibition of cow milk xanthine oxidase at 50 ug/mL
AID566617Antiproliferative activity against human HepG2 cells at 12.5 uM after 48 hrs by MTT assay2010Journal of natural products, Dec-27, Volume: 73, Issue:12
Spectroscopic characterization and antiproliferative activity on HepG2 human hepatoblastoma cells of flavonoid C-glycosides from Petrorhagia velutina.
AID304971Antibacterial activity against Staphylococcus aureus by broth micro-dilution technique2007Bioorganic & medicinal chemistry letters, Jan-01, Volume: 17, Issue:1
New antifungal flavonoid glycoside from Vitex negundo.
AID403597Inhibition of Ca2+-induced Wistar rat thoracic aorta contraction at 150 uM in high K+ medium pretreated 15 mins before addition of Ca2+ and K+ relative to control1997Journal of natural products, Aug, Volume: 60, Issue:8
A new flavone C-glycoside and antiplatelet and vasorelaxing flavones from Gentiana arisanensis.
AID403594Inhibition of platelet activating factor-induced platelet aggregation in rabbit plasma at 300 uM preincubated 3 mins before addition of thrombin by turbidimetric method1997Journal of natural products, Aug, Volume: 60, Issue:8
A new flavone C-glycoside and antiplatelet and vasorelaxing flavones from Gentiana arisanensis.
AID1872912Inhibition of GSK-3beta (unknown origin) using peptide YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate incubated for 5 to 60 mins by ADP-Glo kinase assay2022European journal of medicinal chemistry, Jun-05, Volume: 236Development of inhibitors targeting glycogen synthase kinase-3β for human diseases: Strategies to improve selectivity.
AID1705065Inhibition of biotinylated 5-(4-((Z)-3-Carboxy-3-hydroxyacryloyl)-4-(4-chlorobenzyl)piperidine-1-carbonyl)-2-((13,35-dioxo-39-((3aR,4R,6aS)-2-oxohexahydro-1H-thieno[3,4-d]imidazole-4-yl)-3,6,9,16,19,22,25,28,31-nonaoxa-12,34-diazanonatriacontyl)oxy)benzoi2020European journal of medicinal chemistry, Dec-15, Volume: 208Unraveling the anti-influenza effect of flavonoids: Experimental validation of luteolin and its congeners as potent influenza endonuclease inhibitors.
AID304970Antibacterial activity against Pseudomonas aeruginosa by broth micro-dilution technique2007Bioorganic & medicinal chemistry letters, Jan-01, Volume: 17, Issue:1
New antifungal flavonoid glycoside from Vitex negundo.
AID1236855Retention time of the compound by HPLC-SPE-NMR analysis2015Bioorganic & medicinal chemistry, Jul-01, Volume: 23, Issue:13
Acylated glucosylflavones as α-glucosidase inhibitors from Tinospora crispa leaf.
AID304967Antibacterial activity against Streptococcus faecalis by broth micro-dilution technique2007Bioorganic & medicinal chemistry letters, Jan-01, Volume: 17, Issue:1
New antifungal flavonoid glycoside from Vitex negundo.
AID304976Antifungal activity against Aspergillus fumigatus by broth micro-dilution technique2007Bioorganic & medicinal chemistry letters, Jan-01, Volume: 17, Issue:1
New antifungal flavonoid glycoside from Vitex negundo.
AID566614Antiproliferative activity against human HepG2 cells at 25 uM after 24 hrs by MTT assay2010Journal of natural products, Dec-27, Volume: 73, Issue:12
Spectroscopic characterization and antiproliferative activity on HepG2 human hepatoblastoma cells of flavonoid C-glycosides from Petrorhagia velutina.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (126)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's4 (3.17)18.2507
2000's19 (15.08)29.6817
2010's68 (53.97)24.3611
2020's35 (27.78)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 23.73

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index23.73 (24.57)
Research Supply Index4.93 (2.92)
Research Growth Index5.32 (4.65)
Search Engine Demand Index26.67 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (23.73)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (0.74%)5.53%
Reviews5 (3.68%)6.00%
Case Studies0 (0.00%)4.05%
Observational1 (0.74%)0.25%
Other129 (94.85%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]